Return to site

Cell Counting Market: Growing Incidence of Target Diseases and Blood Disorders

The cell counting market is expected to grow from USD 8.29 billion in 2017 to USD 12.31 billion by 2023, at a CAGR of 6.8%.

· Biotechnology,Healthcare

Cell counting plays a vital role in cell analysis it helps identify the viability of cells and cell growth, and quantifies the number of live or dead cells in cell culture. The advantages of improved image analysis and the growing use of high-throughput Flow Cytometry and automated Hematology Analyzers are aiding the growth of the market. The cell counting market is expanding with the emergence of new technologies and increasing applications areas. These instruments are being used in various research, clinical & diagnostic, and industrial applications. Many life science companies are under pressure to maintain their existing profit margins and improve them in the future while facing enormous pressure to cut prices. This has led to dramatic shifts in the business models of some manufacturers in this industry.

How much is the Cell Counting Market worth?

The cell counting market is expected to grow from USD 8.29 billion in 2017 to USD 12.31 billion by 2023, at a CAGR of 6.8%. The growing incidence of diseases and blood disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers are the key factors driving the growth of this market. North America is expected to register the highest growth rate during the forecast period mainly due to growing incidence rate of various infectious diseases, investment initiatives by the government, and presence of high-quality infrastructure for clinical and laboratory research.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728

By product, the consumables segment is expected to account for the largest share of the cell counting market in 2018

On the basis of product, the consumables segment is expected to account for the largest share of the global cell counting market in 2018. This large share can be attributed to the repeated consumption of consumables and accessories in various cell counting procedures. The growing focus on stem cell and cancer research is one of the major drivers for the growth of the cell counting consumables market along with the growing application of cell counting in quality control procedures in various industries, such as food and beverage, pharmaceutical, biotechnology products manufacturing, environmental monitoring, and water treatment.

By application, the research applications segment is estimated to hold the largest share in 2018

Based on application, the cell counting market is segmented into research applications, clinical & diagnostic applications, and industrial applications. In 2018, the research applications segment is expected to account for the largest share of the cell counting market. The large share of this segment can be attributed to the growing adoption of various cell counting instruments in research activities propelled by increasing research activities being undertaken for cancer, immunology, infectious diseases, HIV, drug discovery, and stem cells.

By end user, the research institutes segment is estimated to hold the largest share of the cell counting market in 2018

On the basis of end user, the cell counting market is segmented into research institutes, hospitals, clinical laboratories, pharmaceutical & biotechnology companies, and other end users (food and beverage companies and environmental testing companies). The research institutes segment is expected to account for the largest share in 2018. A surge in cell-based research and increasing research investment in the field of AIDS, cancer, infectious diseases, and blood disorders are some of the factors driving the growth of this market segment.

North America is expected to dominate the cell counting market in 2018

This report covers the market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of te World (RoW). Of the four geographic regions studied in the report, North America is expected to register the highest growth rate during the forecast period mainly due to growing incidence rate of various infectious diseases, investment initiatives by the government, and presence of high-quality infrastructure for clinical and laboratory research.

Geographically, the cell counting market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to account for the largest share of the cell counting market in 2018, followed by Europe and Asia Pacific. With significant growth in the research industry in the past few years, China and India have emerged as high-growth markets for cell counting instruments. Other than these APAC countries, Brazil also shows significant growth potential for the cell counting market.

Request for Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=157450728

Leading Companies

The major players in the market include Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck (Germany), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Agilent Technologies (US), BioTek Instruments (US), Tecan Group (Switzerland), Roche Diagnostics (Switzerland), Sysmex Corporation (Japan), HORIBA, Ltd. (Japan), Abbott Laboratories (US), and Siemens Healthineers (Germany).

For more information @ https://www.marketsandmarkets.com/PressReleases/cell-counting.asp

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly